GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zafgen Inc (NAS:ZFGN) » Definitions » Cash Flow for Lease Financing

Zafgen (Zafgen) Cash Flow for Lease Financing : $0.00 Mil (TTM As of Mar. 2020)


View and export this data going back to 2014. Start your Free Trial

What is Zafgen Cash Flow for Lease Financing?

Zafgen's Cash Flow for Lease Financing for the three months ended in Mar. 2020 was $0.00 Mil. Zafgen's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2020 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Dec. 2019 ), Zafgen's Cash Flow for Lease Financing remained the same in Mar. 2020 ($0.00 Mil).

Zafgen Cash Flow for Lease Financing Historical Data

The historical data trend for Zafgen's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zafgen Cash Flow for Lease Financing Chart

Zafgen Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only - - - - -

Zafgen Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Zafgen Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zafgen Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Zafgen's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Zafgen (Zafgen) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zafgen Inc (NAS:ZFGN) » Definitions » Cash Flow for Lease Financing
Comparable Companies
MACK ZIVO ALNA ADXS LPCN OPNT QBIO PULM VBLT FWP OCSE:NOVO B ASX:CSL VRTX REGN XKRX:207940 SGEN MRNA ALXN XKRX:068270 INCY
Traded in Other Exchanges
N/A
Address
3 Center Plaza, Suite 610, Boston, MA, USA, 02108
Website
http://www.zafgen.com
Zafgen Inc is a US-based biopharmaceutical company. It focuses on developing novel therapeutics that treat the underlying biological mechanisms through the methionine aminopeptidase 2, or MetAP2, pathway. The lead product candidate of the company is ZGN-1061 which is a novel fumagillin-class MetAP2 inhibitor administered by subcutaneous injection. The company operates in the business of developing novel therapeutics. The company primarily carries its business operations in the United States.